[HTML][HTML] Tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting β2-agonists
P Santus, S Centanni, N Morelli, F Di Marco… - Respiratory …, 2007 - Elsevier
In a three-way crossover pilot study, the acute effects of tiotropium 18μg inhalation on the
respiratory function and arterial blood gas tensions of 30 patients with stable chronic …
respiratory function and arterial blood gas tensions of 30 patients with stable chronic …
Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive …
YS Punekar, G Roberts, A Ismaila… - Cost Effectiveness and …, 2015 - Springer
Background The cost-effectiveness of umeclidinium bromide-vilanterol (UMEC/VI) versus
tiotropium monotherapy in the UK was assessed using a UMEC/VI treatment-specific …
tiotropium monotherapy in the UK was assessed using a UMEC/VI treatment-specific …
Bronchodilator combination therapy for the treatment of chronic obstructive pulmonary disease
S Sethi, C Cote - Current Clinical Pharmacology, 2011 - ingentaconnect.com
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality,
and its prevalence is rising worldwide. Bronchodilators remain the cornerstone of COPD …
and its prevalence is rising worldwide. Bronchodilators remain the cornerstone of COPD …
Chronic obstructive pulmonary disease: an evidence-based approach to treatment with a focus on anticholinergic bronchodilation
NJ Gross - Mayo Clinic Proceedings, 2008 - Elsevier
Chronic obstructive pulmonary disease is a prevalent condition associated with a high
societal burden. Despite a decrease in the prevalence of smoking in the United States, the …
societal burden. Despite a decrease in the prevalence of smoking in the United States, the …
Olodaterol+ tiotropium bromide for the treatment of COPD
L Calzetta, C Ciaprini, E Puxeddu… - Expert Review of …, 2016 - Taylor & Francis
Patients suffering from COPD not controlled by a single bronchodilator should be given two
bronchodilators with different mechanisms of action. Addition of a LABA to a LAMA induces …
bronchodilators with different mechanisms of action. Addition of a LABA to a LAMA induces …
Evolving endoscopic approaches for treatment of emphysema
EP Ingenito, LW Tsai - Seminars in thoracic and cardiovascular surgery, 2007 - Elsevier
Novel endobronchial methods for reducing lung volume in patients with advanced
emphysema are currently being evaluated in clinical trials as potential alternatives to lung …
emphysema are currently being evaluated in clinical trials as potential alternatives to lung …
[PDF][PDF] Effect of dual bronchodilation with QVA149 on cardiac safety in healthy volunteers
A Drollmann, M Brown, R Sechaud, S Perry… - Int J Clin Pharmacol …, 2014 - researchgate.net
Objectives: QVA149 is a dual bronchodilator, containing a fixed-dose combination of the
long-acting β2-agonist indacaterol and long-acting muscarinic antagonist glycopyrronium …
long-acting β2-agonist indacaterol and long-acting muscarinic antagonist glycopyrronium …
Optimizing bronchodilator therapy in emphysema
PT Diaz, AS Bruns, ME Ezzie, N Marchetti… - Proceedings of the …, 2008 - atsjournals.org
The treatment objectives for chronic obstructive pulmonary disease (COPD) include
relieving symptoms such as dyspnea and cough, slowing the accelerated decline in lung …
relieving symptoms such as dyspnea and cough, slowing the accelerated decline in lung …